Active Not Recruiting PHASE1 Interventional 1-arm
NCT01999491
A Phase 1 Dose-Escalation and Pharmacokinetic Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma
Sponsor: M.D. Anderson Cancer Center
Conditions
Advanced Cancers Lymphoma
Interventions
NC-4016
Updated 3 times since 2017 Last updated: Nov 26, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1 trial investigates Advanced Cancers and Lymphoma and is currently ongoing. M.D. Anderson Cancer Center leads this study, which shows 3 recorded versions since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
3 versions recorded-
May 2017 — Present [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- M.D. Anderson Cancer Center
- NanoCarrier Co., Ltd.
Data source: M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .